Globus Medical, Inc. (GMED)
| Previous close | 51.20 |
| Open | 51.17 |
| Bid | 51.37 x 800 |
| Ask | 51.41 x 1200 |
| Day's range | 50.98 - 51.54 |
| 52-week range | 43.39 - 62.88 |
| Volume | |
| Avg. volume | 1,072,748 |
| Market cap | 6.942B |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | 47.93 |
| EPS (TTM) | 1.07 |
| Earnings date | 02 May 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 61.46 |
GlobeNewswireGlobus Medical Schedules First Quarter Earnings Release and Conference Call
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m.
ZacksWhy Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ZacksGlobus Medical (GMED) Gains From New Launches Amid Macro Issues
Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
